First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
Recruiting · NCT07412288 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants | Healthy Participants | Recruiting | Phase 1 | 2026-02-27 | NCT07412288 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kymera Therapeutics, Inc. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Celerion | Lincoln | United States | 6 |